Director, Genotyping and Microarray Center
Principal Investigator, National Institute of Aging Repository
"The availability of genome-based technologies holds incredible potential for improving how each of our medical decision is made. It's a fascinating time to be involved in this progressive area of research."
Norman Gerry, PhD, is a genomics expert at Coriell Institute and the principal investigator of the National Institute of Aging (NIA) Repository, which is committed to distributing well-characterized cell and DNA samples for studies of aging. Norman is also the director of the Coriell Genotyping and Microarray Center, a high-throughput facility capable of analyzing 2,000 DNA or RNA samples per month. The facility also performs the genome analyses for the Coriell Personalized Medicine Collaborative® (CPMC®), a research study that aims to evaluate the utility of using the knowledge of genetics in medicine.
Prior to joining Coriell, Norman was Director of the Microarray Resource at Boston University. He has been involved in microarray and DNA testing for several years and has successfully processed thousands of single nucleotide polymorphism (SNP) and gene expression arrays, including all of the genotyping from the first genome scan of the Framingham Heart Study [Herbert et al. (2006), Science; Herbert et al. (2007), Nature Genetics]. Norman has also authored or co-authored numerous peer-reviewed scientific publications.
After earning his undergraduate degree in chemistry from Ithaca College, Norman continued his studies in chemistry, earning his doctorate degree from Purdue University.